Abstract
Purpose
Diverse commercial implantable medical devices were developed for the convenience and life-quality of patients, and tether-free diagnostics and therapeutics. Those devices need implantable cable, which connects each part of their devices for transcutaneous energy or signal transfer. For prolonged implantation into human body, it should be safe, robust, and be long-term operable without failure. In this paper, we introduce an implantable PDMS-coated cable.
Methods
By using PDMS as an encapsulation material, we developed a biocompatible, flexible and durable cable. Several tests were carried out for the evaluation of cable performance. Leakage test confirmed that coating using PDMS was sufficient to prevent the invasion of body fluid to conducting wire. Tensile test, torsion-durability test and bending-durability test demonstrated its mechanical durability and robustness to motion. The resistance variation recorded in the durability test was monitored to verify the electrical stability during movement of cable. Experiments of subcutaneous tissue implantation for 8 weeks were performed to observe the degree of biocompatibility as an implantable cable.
Results & conclusions
Our cable was mechanically stable and biocompatible enough to be used for long term implantable medical devices.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Donaldson PE. The Cooper cable: an implantable multiconductor cable for neurological prostheses. Med Biol Eng Comput. 1983; 21(3):371–374.
Marino JC. Flexible connector for implantable wiring harness. In.: US Patent App. 20,080/009,198; 2005.
Kaplan PM, Cross Jr TE, Bolea SL, Olsen JM. Implantable medical lead with axially oriented coiled wire conductors. In.: Google Patents; 2010.
O’brien RC. Implantable electrical lead wire. In.: EP Patent 1,547,647; 2005.
Kitamura S, Satomi K, Kurita T, Shimizu W, Suyama K, Aihara N, Niwaya K, Kobayashi J, Kamakura S. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J. 2006; 70(3):273–277.
Ward B, Anderson J, Ebert M, McVenes R, Stokes K. In vivo biostability of polysiloxane polyether polyurethanes: resistance to metal ion oxidation. J Biomed Mater Res A. 2006; 77(2):380–389.
Ward R, Anderson J, McVenes R, Stokes K. In vivo biostability of polyether polyurethanes with fluoropolymer and polyethylene oxide surface modifying endgroups; resistance to metal ion oxidation. J Biomed Mater Res A. 2007; 80(1):34–44.
Szycher M, Reed AM, Siciliano AA. In vivo testing of a biostable polyurethane. J Biomat Appl. 1991; 6(2):110–130.
Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003; 41(1):73–80.
Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circ. 2007; 115(19): 2474–2480.
Hauser RG, Cannom D, Hayes DL, Parsonnet V, Hayes J, Ratliff N, 3rd, Tyers GF, Epstein AE, Vlay SC, Furman S et al. Longterm structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2002; 25(6):879–882.
Luo YL, Nan YF, Xu F, Chen YS, Zhao P. Degradation behavior and biocompatibility of PEG/PANI-derived polyurethane copolymers. J Biomat Sci-Polym E. 2010; 21(8–9):1143–1172.
Stachelek SJ, Alferiev I, Ueda M, Eckels EC, Gleason KT, Levy RJ. Prevention of polyurethane oxidative degradation with phenolic antioxidants covalently attached to the hard segments: structure-function relationships. J Biomed Mater Res A. 2010; 94(3):751–759.
Zuidema J, van Minnen B, Span MM, Hissink CE, van Kooten TG, Bos RR. In vitro degradation of a biodegradable polyurethane foam, based on 1,4-butanediisocyanate: a three-year study at physiological and elevated temperature. J Biomed Mater Res A. 2009; 90(3):920–930.
Stachelek SJ, Alferiev I, Choi H, Chan CW, Zubiate B, Sacks M, Composto R, Chen IW, Levy RJ. Prevention of oxidative degradation of polyurethane by covalent attachment of di-tertbutylphenol residues. J Biomed Mater Res A. 2006; 78(4):653–661.
van Minnen B, Stegenga B, van Leeuwen MB, van Kooten TG, Bos RR. A long-term in vitro biocompatibility study of a biodegradable polyurethane and its degradation products. J Biomed Mater Res A. 2006; 76(2):377–385.
Gorna K, Gogolewski S. Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J Biomed Mater Res A. 2003; 67(3):813–827.
Belanger MC, Marois Y. Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review. J Biomed Mater Res. 2001; 58(5):467–477.
Park J, Yoo S, Lee E-J, Lee D, Kim J, Lee S-H. Increased poly(dimethylsiloxane) stiffness improves viability and morphology of mouse fibroblast cells. BioChip J. 2010; 4(3):230–236.
Peterson SL, McDonald A, Gourley PL, Sasaki DY. Poly(dimethylsiloxane) thin films as biocompatible coatings for microfluidic devices: Cell culture and flow studies with glial cells. J Biomed Mater Res Part A. 2005; 72A(1):10–18.
Author information
Authors and Affiliations
Corresponding author
Additional information
equally contributed author
Rights and permissions
About this article
Cite this article
Kim, S.H., Moon, JH., Kim, J.H. et al. Flexible, stretchable and implantable PDMS encapsulated cable for implantable medical device. Biomed. Eng. Lett. 1, 199–203 (2011). https://doi.org/10.1007/s13534-011-0033-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13534-011-0033-8